Enzychem

183490.KQ

Tags: KR Healthcare Drug Manufacturers - Specialty & Generic

Enzychem Lifesciences Corporation Price (183490.KQ)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

84,929,236

(7.751)%

Market Cap of Enzychem (183490.KQ)

Market cap:

As of , 183490.KQ has a market cap of . This makes 183490.KQ the 179th most valuable company in the KR by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Enzychem Lifesciences Corporation, a pharmaceutical company, focuses on the development of oral small molecule therapies for patients with unmet medical needs for oncology, metabolic diseases, and inflammatory diseases in South Korea. It is also developing potential therapies based on EC-18 technology platform to treat chemotherapy-induced neutropenia, chemoradiation therapy-induced oral mucositis, and acute radiation syndrome. The company was founded in 1999 and is headquartered in Seoul, South Korea. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $1047-2220
Market Cap 99.80B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

ceo: Ki-Young Sohn
IPO Date: April, 05, 2017
Country: KR
Currency: KRW
Headquaters: Seoul,
Employees: 122

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: